Skip Nav Destination
Issues
August 2024
eISSN 2168-9709
APPLIED PSYCHOPHARMACOLOGY
ORIGINAL RESEARCH
LITERATURE REVIEW
INNOVATIVE PRACTICE
Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
Amber R. Douglass, PharmD, BCPS, BCPP; Ashley Maister, PharmD, BCPP; Karen E. Moeller, PharmD, BCPP; Aaron Salwan, PharmD, MPH, BCPP; Anuja Vallabh, PharmD, BCPP; Kristin Waters, PharmD, BCPP, BCPS; Gregory H. Payne, MBA, CAE
-
Cover Image
Cover Image
![issue cover]()
Comparison of intramuscular haloperidol and other short-acting injectable antipsychotics for management of acute agitation in an adult inpatient psychiatry unit
Sarah Gamcsik, PharmD, Katie S. Adams, PharmD, BCPP, BCPS
Implementation of a practice model for inpatient psychiatric clinical pharmacist practitioners with prescriptive authority at a veterans health care facility
Chinedu Diokpa, PharmD, Courtney Givens, PharmD
An interdisciplinary intervention for detection of sexual dysfunction associated with antidepressants: A pilot study
Pia-Allison Roa, PharmD, Jolene R. Bostwick, PharmD, BCPS, BCPP, Paresh D. Patel, MD, PhD, Joanna Quigley, MD, Amy N. Thompson, PharmD, BCACP, Kristen M. Ward, PharmD, BCPP
Standardized reporting on studies of psychiatric pharmacist interventions
Brittany L. Parmentier, PharmD, MPH, BCPS, BCPP, Jonathan F. Lister, PharmD, BCPP, Tera D. Moore, PharmD, BCACP, Kristina Reinstatler, PharmD, MBA, BCPP, Ranel Troy Santos, PharmD, BCPP, Gregory H. Payne, MBA, CAE
Exploring the harm reduction paradigm: the role of Board-Certified Psychiatric Pharmacists
Amber R. Douglass, PharmD, BCPS, BCPP, Ashley Maister, PharmD, BCPP, Karen E. Moeller, PharmD, BCPP, Aaron Salwan, PharmD, MPH, BCPP, Anuja Vallabh, PharmD, BCPP, Kristin Waters, PharmD, BCPP, BCPS, Gregory H. Payne, MBA, CAE